{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:11:24Z","timestamp":1790777484021,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000262","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000262","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019347","name":"Tistou and Charlotte Kerstan Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jconrel.2026.114670","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T16:46:26Z","timestamp":1769618786000},"page":"114670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Ocular delivery of different valosin-containing protein (VCP) inhibitory formulations prevents retinal degeneration in rho\u2206I255 mice"],"prefix":"10.1016","volume":"392","author":[{"given":"Bowen","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Cristina","family":"Almansa-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regine","family":"M\u00fchlfriedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias W.","family":"Seeliger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Petremann-Dum\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Kilger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneli","family":"Vollert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Bolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Henes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Caliceti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Salmaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Ueffing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Arango-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114670_bb0005","first-page":"26","article-title":"A 3-bp deletion in the rhodopsin gene in a family with autosomal dominant retinitis pigmentosa","volume":"48","author":"Inglehearn","year":"1991","journal-title":"Am.J.Hum.Genet."},{"key":"10.1016\/j.jconrel.2026.114670_bb0010","doi-asserted-by":"crossref","first-page":"26645","DOI":"10.1016\/S0021-9258(19)74360-9","article-title":"Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain","volume":"268","author":"Sung","year":"1993","journal-title":"J.Biol.Chem."},{"key":"10.1016\/j.jconrel.2026.114670_bb0015","first-page":"844","article-title":"Spectrum of rhodopsin mutations in Korean patients with retinitis pigmentosa","volume":"17","author":"Kim","year":"2011","journal-title":"Mol. Vis."},{"key":"10.1016\/j.jconrel.2026.114670_bb0020","series-title":"In Retinal Degeneration: Clinical and Laboratory Applications","first-page":"103","author":"Lorenz","year":"1993"},{"key":"10.1016\/j.jconrel.2026.114670_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170038","article-title":"Mutations in splicing factor genes are a major cause of autosomal dominant retinitis pigmentosa in Belgian families","volume":"12","author":"Van Cauwenbergh","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jconrel.2026.114670_bb0030","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.bbrc.2010.09.004","article-title":"Mutation spectrum and frequency of the RHO gene in 248 Chinese families with retinitis pigmentosa","volume":"401","author":"Li","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2026.114670_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1240067","article-title":"Clinical and genetic features of Koreans with retinitis pigmentosa associated with mutations in rhodopsin","volume":"14","author":"Jung","year":"2023","journal-title":"Front. Genet."},{"key":"10.1016\/j.jconrel.2026.114670_bb0040","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1016\/j.ymthe.2020.08.012","article-title":"Therapy in rhodopsin-mediated autosomal dominant retinitis pigmentosa","volume":"28","author":"Meng","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.114670_bb0045","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K","article-title":"Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies","volume":"17","author":"Sohocki","year":"2001","journal-title":"Hum.Mutat."},{"key":"10.1016\/j.jconrel.2026.114670_bb0050","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1021\/bi00708a031","article-title":"Rhodopsin content in the outer segment membranes of bovine and frog retinal rods","volume":"13","author":"Papermaster","year":"1974","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2026.114670_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1132179","article-title":"Rhodopsin-associated retinal dystrophy: disease mechanisms and therapeutic strategies","volume":"17","author":"Zhen","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jconrel.2026.114670_bb0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/humu.1380020403","article-title":"Rhodopsin mutations in autosomal dominant retinitis pigmentosa","volume":"2","author":"Al-Maghtheh","year":"1993","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.jconrel.2026.114670_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1369000","article-title":"Mutant dominant-negative rhodopsin(\u2206I256) causes protein aggregates degraded via ERAD and prevents normal rhodopsin from proper membrane trafficking","volume":"11","author":"Cao","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jconrel.2026.114670_bb0070","article-title":"Autosomal dominant retinitis pigmentosa caused by the rhodopsin isoleucine 255 deletion features rapid neuroretinal degeneration, decreased synaptic connectivity, and neuroinflammation","volume":"2024","author":"Cao","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.jconrel.2026.114670_bb0075","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/ncb3238","article-title":"Systematic proteomics of the VCP-UBXD adaptor network identifies a role for UBXN10 in regulating ciliogenesis","volume":"17","author":"Raman","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.114670_bb0080","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.1523\/JNEUROSCI.5397-12.2013","article-title":"Tau accumulation activates the unfolded protein response by impairing endoplasmic reticulum-associated degradation","volume":"33","author":"Abisambra","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2026.114670_bb0085","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.brainres.2016.04.021","article-title":"Endoplasmic reticulum stress in human photoreceptor diseases","volume":"1648","author":"Chan","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.jconrel.2026.114670_bb0090","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.bbamcr.2010.01.008","article-title":"Clearance of rhodopsin(P23H) aggregates requires the ERAD effector VCP","volume":"1803","author":"Griciuc","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jconrel.2026.114670_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001075","article-title":"Inactivation of VCP\/ter94 suppresses retinal pathology caused by misfolded rhodopsin in Drosophila","volume":"6","author":"Griciuc","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.jconrel.2026.114670_bb0100","doi-asserted-by":"crossref","first-page":"34150","DOI":"10.1074\/jbc.M204955200","article-title":"A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system","volume":"277","author":"Illing","year":"2002","journal-title":"J.Biol.Chem."},{"key":"10.1016\/j.jconrel.2026.114670_bb0105","doi-asserted-by":"crossref","first-page":"5961","DOI":"10.1073\/pnas.0911991107","article-title":"Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP\/Grp78","volume":"107","author":"Gorbatyuk","year":"2010","journal-title":"Proc.Natl.Acad.Sci.U.S.A"},{"key":"10.1016\/j.jconrel.2026.114670_bb0110","article-title":"Inhibition of VCP preserves retinal structure and function in autosomal dominant retinal degeneration","author":"Arango-Gonzalez","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.jconrel.2026.114670_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/biom11101528","article-title":"Pharmacological inhibition of the VCP\/proteasome axis rescues photoreceptor degeneration in RHO(P23H) rat retinal explants","volume":"11","author":"Sen","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.jconrel.2026.114670_bb0120","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nature02656","article-title":"A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol","volume":"429","author":"Ye","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114670_bb0125","first-page":"4735","article-title":"Inhibition of valosin-containing protein (VCP) prevents retinal degeneration in P23H transgenic rats, a model for autosomal dominant RP","volume":"65","author":"Arango-Gonzalez","year":"2024","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2026.114670_bb0130","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s12951-023-01992-2","article-title":"Nanotechnology-based ocular drug delivery systems: recent advances and future prospects","volume":"21","author":"Li","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114670_bb0135","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1097\/MS9.0000000000001399","article-title":"Drug delivery methods based on nanotechnology for the treatment of eye diseases","volume":"85","author":"Oucif Khaled","year":"2023","journal-title":"Ann. Med. Surg. (Lond.)"},{"key":"10.1016\/j.jconrel.2026.114670_bb0140","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1517\/17425247.2014.935338","article-title":"Advances in ocular drug delivery: emphasis on the posterior segment","volume":"11","author":"Kang-Mieler","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.114670_bb0145","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jconrel.2012.06.018","article-title":"Self-assembling nanocomposites for protein delivery: supramolecular interactions between PEG-cholane and rh-G-CSF","volume":"162","author":"Salmaso","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114670_bb0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2016.02.009","article-title":"A novel combined strategy for the physical PEGylation of polypeptides","volume":"226","author":"Ambrosio","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114670_bb0155","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.canlet.2020.11.028","article-title":"Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of hedgehog-dependent medulloblastoma","volume":"499","author":"Infante","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.114670_bb0160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijpharm.2015.08.070","article-title":"A novel performing PEG-cholane nanoformulation for amphotericin B delivery","volume":"495","author":"Luengo-Alonso","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114670_bb0165","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jconrel.2021.09.039","article-title":"Retinal neuroprotection by controlled release of a VCP inhibitor from self-assembled nanoparticles","volume":"339","author":"Sen","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114670_bb0170","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/bph.12330","article-title":"Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy","volume":"170","author":"Guzman-Aranguez","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.114670_bb0175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/fcp.12561","article-title":"Progress on ocular siRNA gene-silencing therapy and drug delivery systems","volume":"35","author":"Jiang","year":"2021","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2026.114670_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118712","article-title":"Small interfering RNAs (siRNAs) based gene silencing strategies for the treatment of glaucoma: recent advancements and future perspectives","volume":"264","author":"Naik","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.jconrel.2026.114670_bb0185","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s11095-017-2134-2","article-title":"The race of 10 synthetic RNAi-based drugs to the pharmaceutical market","volume":"34","author":"Titze-de-Almeida","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2026.114670_bb0190","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-019-0017-4","article-title":"The current state and future directions of RNAi-based therapeutics","volume":"18","author":"Setten","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114670_bb0195","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4155\/tde.11.37","article-title":"MagnetofectionTM platform: from magnetic nanoparticles to novel nucleic acid therapeutics","volume":"2","author":"Plank","year":"2011","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2026.114670_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13081157","article-title":"Advantages and disadvantages of using magnetic nanoparticles for the treatment of complicated ocular disorders","volume":"13","author":"Schneider-Futschik","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114670_bb0205","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/sj.gt.3301624","article-title":"Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo","volume":"9","author":"Scherer","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2026.114670_bb0210","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1021\/acs.bioconjchem.1c00132","article-title":"New method for efficient siRNA delivery in retina explants: reverse Magnetofection","volume":"32","author":"Bassetto","year":"2021","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2026.114670_bb0215","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020225","article-title":"Efficient ocular delivery of VCP siRNA via reverse Magnetofection in RHO P23H rodent retina explants","volume":"13","author":"Sen","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114670_bb0220","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/cmdc.201402420","article-title":"Evaluating p97 inhibitor analogues for their domain selectivity and potency against the p97-p47 complex","volume":"10","author":"Fang","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jconrel.2026.114670_bb0225","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nchembio.1313","article-title":"Covalent and allosteric inhibitors of the ATPase VCP\/p97 induce cancer cell death","volume":"9","author":"Magnaghi","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jconrel.2026.114670_bb0230","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1167\/iovs.09-4741","article-title":"In vivo and in vitro development of S- and M-cones in rat retina","volume":"51","author":"Arango-Gonzalez","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2026.114670_bb0235","first-page":"1553","article-title":"The autosomal dominant Rholle256del mutation causes protein aggregation and is processed by the VCP-dependent ERAD pathway","volume":"64","author":"Cao","year":"2023","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2026.114670_bb0240","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1242\/jcs.115.14.2907","article-title":"The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation","volume":"115","author":"Saliba","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2026.114670_bb0245","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/s41467-024-45748-4","article-title":"Aggregation of rhodopsin mutants in mouse models of autosomal dominant retinitis pigmentosa","volume":"15","author":"Vasudevan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114670_bb0250","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejpb.2015.01.003","article-title":"Intravitreal clearance and volume of distribution of compounds in rabbits: in silico prediction and pharmacokinetic simulations for drug development","volume":"95","author":"del Amo","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2026.114670_bb0255","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/2211-5463.12193","article-title":"Toxic effects of dimethyl sulfoxide on red blood cells, platelets, and vascular endothelial cells in vitro","volume":"7","author":"Yi","year":"2017","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.jconrel.2026.114670_bb0260","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jconrel.2021.05.010","article-title":"PEG-polyaminoacid based micelles for controlled release of doxorubicin: rational design, safety and efficacy study","volume":"335","author":"Brunato","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114670_bb0265","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molmed.2005.02.007","article-title":"Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy","volume":"11","author":"Mendes","year":"2005","journal-title":"Trends Mol.Med."},{"key":"10.1016\/j.jconrel.2026.114670_bb0270","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.1146361","article-title":"IRE1 signaling affects cell fate during the unfolded protein response","volume":"318","author":"Lin","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114670_bb0275","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/421127a","article-title":"Atomic-force microscopy: rhodopsin dimers in native disc membranes","volume":"421","author":"Fotiadis","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114670_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154779","article-title":"Limited ATF4 expression in degenerating retinas with ongoing ER stress promotes photoreceptor survival in a mouse model of autosomal dominant retinitis pigmentosa","volume":"11","author":"Bhootada","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jconrel.2026.114670_bb0285","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ceb.2010.11.003","article-title":"Signaling cell death from the endoplasmic reticulum stress response","volume":"23","author":"Shore","year":"2011","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.jconrel.2026.114670_bb0290","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-genet-102108-134850","article-title":"The role of mitochondria in apoptosis*","volume":"43","author":"Wang","year":"2009","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.jconrel.2026.114670_bb0295","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1080\/15548627.2022.2052461","article-title":"WIPI2 positively regulates mitophagy by promoting mitochondrial recruitment of VCP","volume":"18","author":"Lu","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.jconrel.2026.114670_bb0300","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1523\/JNEUROSCI.2982-13.2014","article-title":"Proteomic survey reveals altered energetic patterns and metabolic failure prior to retinal degeneration","volume":"34","author":"Griciuc","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jconrel.2026.114670_bb0305","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/pedi.12162","article-title":"Change in adiposity minimally affects the lipid profile in youth with recent onset type 1 diabetes","volume":"16","author":"Shah","year":"2015","journal-title":"Pediatr. Diabetes"},{"key":"10.1016\/j.jconrel.2026.114670_bb0310","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/978-1-61779-474-2_32","article-title":"Cellular responses to misfolded proteins and protein aggregates","volume":"832","author":"Houck","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2026.114670_bb0315","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1074\/jbc.M114.580324","article-title":"Combining valosin-containing protein (VCP) inhibition and suberanilohydroxamic acid (SAHA) treatment additively enhances the folding, trafficking, and function of epilepsy-associated gamma-aminobutyric acid, type A (GABAA) receptors","volume":"290","author":"Han","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.114670_bb0320","doi-asserted-by":"crossref","first-page":"47358","DOI":"10.1074\/jbc.M207783200","article-title":"Functional ATPase activity of p97\/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells","volume":"277","author":"Kobayashi","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.114670_bb0325","doi-asserted-by":"crossref","first-page":"17369","DOI":"10.1074\/jbc.M600509200","article-title":"Selective inhibition of endoplasmic reticulum-associated degradation rescues DeltaF508-cystic fibrosis transmembrane regulator and suppresses interleukin-8 levels: therapeutic implications","volume":"281","author":"Vij","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2026.114670_bb0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntm.2024.100056","article-title":"Nanotechnology-based advancements for effective delivery of phytoconstituents for ocular diseases","volume":"3","author":"Krishnaswami","year":"2024","journal-title":"Nano TransMed"},{"key":"10.1016\/j.jconrel.2026.114670_bb0335","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jconrel.2020.10.028","article-title":"Ocular barriers to retinal delivery of intravitreal liposomes: impact of vitreoretinal interface","volume":"328","author":"Tavakoli","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114670_bb0340","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.biomaterials.2012.01.030","article-title":"The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection","volume":"33","author":"Koo","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2026.114670_bb0345","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.drudis.2019.05.005","article-title":"Intravitreal nanoparticles for retinal delivery","volume":"24","author":"Huang","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2026.114670_bb0350","doi-asserted-by":"crossref","first-page":"11372","DOI":"10.1128\/JVI.01327-07","article-title":"Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors","volume":"81","author":"Allocca","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jconrel.2026.114670_bb0355","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013392","article-title":"Novel AAV capsids for intravitreal gene therapy of photoreceptor disorders","volume":"13","author":"Pavlou","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jconrel.2026.114670_bb0360","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/gt.2011.3","article-title":"AAV-mediated photoreceptor transduction of the pig cone-enriched retina","volume":"18","author":"Mussolino","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2026.114670_bb0365","doi-asserted-by":"crossref","first-page":"15016","DOI":"10.1038\/mtm.2015.16","article-title":"Efficient gene delivery to photoreceptors using AAV2\/rh10 and rescue of the rho(\u2212\/\u2212) mouse","volume":"2","author":"Palfi","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.jconrel.2026.114670_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/99ee1789-a658-4fb0-8593-40a40e9f344a","article-title":"Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors","volume":"8","author":"Kay","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jconrel.2026.114670_bb0375","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.visres.2007.07.027","article-title":"Versatility of AAV vectors for retinal gene transfer","volume":"48","author":"Surace","year":"2008","journal-title":"Vis. Res."},{"key":"10.1016\/j.jconrel.2026.114670_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.975803","article-title":"Immunogenicity and toxicity of AAV gene therapy","volume":"13","author":"Ertl","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114670_bb0385","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1073\/pnas.2235688100","article-title":"Electroporation and RNA interference in the rodent retina in vivo and in vitro","volume":"101","author":"Matsuda","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jconrel.2026.114670_bb0390","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrg2006","article-title":"Strategies for silencing human disease using RNA interference","volume":"8","author":"Kim","year":"2007","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2026.114670_bb0395","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202417363","article-title":"Magnetic-guided delivery of antisense oligonucleotides for targeted transduction in multiple retinal explant and organoid models","volume":"12","author":"Ye","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114670_bb0400","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0891-0618(01)00140-5","article-title":"Mouse retina explants after long-term culture in serum free medium","volume":"22","author":"Caffe","year":"2001","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.jconrel.2026.114670_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007507","article-title":"Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography","volume":"4","author":"Fischer","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jconrel.2026.114670_bb0410","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1167\/iovs.09-3724","article-title":"Spectral domain optical coherence tomography in mouse models of retinal degeneration","volume":"50","author":"Huber","year":"2009","journal-title":"Invest Ophthalmol.Vis.Sci."},{"key":"10.1016\/j.jconrel.2026.114670_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100080","article-title":"Towards a quantitative OCT image analysis","volume":"9","author":"Garcia Garrido","year":"2014","journal-title":"PLoS ONE"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926000714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926000714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T08:44:12Z","timestamp":1787129052000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926000714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":83,"alternative-id":["S0168365926000714"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114670","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular delivery of different valosin-containing protein (VCP) inhibitory formulations prevents retinal degeneration in rho\u2206I255 mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114670"}}